Desk›Chemicals› Archean Chemical Industries Ltd
Archean Chemical Industries Ltd
BSE 543657 · NSE ACI · ISIN INE128X01021 · Group A · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹485.00
+0.10%
BSE close, 28 August 2026
₹5,987.73 cr
12.3 cr shares · Small cap
₹2,782.16 cr
as published
41.9× · 3.39×
EPS ₹11.59 · BV ₹143.07
1,041.54 / 154.37
₹ cr, as filed
11
3 selected · 27%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -33.2% |
|---|---|
| Against 52-week low | +0.9% |
| Day change | +0.10% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹11.59 |
|---|---|
| Price / earnings | 41.85× |
| Price / book | 3.39× |
| Book value — derived, price ÷ P/B | ₹143.07 |
| Return on equity | 8.10% |
| Operating margin | 26.55% |
| Net margin | 12.83% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 8.10%
- ROE as published
- 8.10%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 315.93 | 40.53 | 3.28 | 26.55% | 12.83% |
| Mar-26 · Q | 292.28 | 29.76 | 2.41 | 22.72% | 10.18% |
| FY25-26 | 1,041.54 | 154.37 | 12.51 | 29.58% | 14.82% |
Quarter on quarter
- Revenue, quarter on quarter
- +8.1%
- Net profit, quarter on quarter
- +36.2%
- Operating margin, quarter on quarter
- +383 bps
Disclosure profile 11 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| SAST | 4 |
| Analyst / Investor Meet | 2 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 8 |
| Total | 11 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
11 filings · 3 selected · busiest 2026-07-30 and 2026-07-31
Filing rhythm · the twelve most recent
2026-07-242026-09-24
SelectedProcedural
Filings
11 in the window · 13 earlier on record
-
24 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
23 September 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 23, 2026 for Chemikas Speciality LLP
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
9 September 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
7 August 2026 ·
Earnings Call Transcript
Earnings call Transcript
Company Update / Earnings Call Transcript View filing →
-
3 August 2026 ·
Analyst / Investor Meet - Outcome
Earnings Call Recording
Company Update / Analyst / Investor Meet View filing →
-
31 July 2026 ·
Newspaper Publication
Newspaper Publication of Financial Result
Company Update / Newspaper Publication View filing →
-
31 July 2026 ·
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
-
30 July 2026 ·
Board Meeting Outcome - 30.07.2026
Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.
Result / Financial Results View filing →
-
30 July 2026 ·
Board Meeting Outcome for Board Meeting Outcome 30.07.2026
Outcome of the Board Meeting held on July 30, 2026 1. The Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Pursuant to Regulation 33(3) of ....
Board Meeting / Outcome of Board Meeting View filing →
-
28 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule for Earnings Call
Company Update / Analyst / Investor Meet View filing →
-
24 July 2026 ·
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2026 for Chemikas Speciality LLP
Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →
RSS feed for Archean Chemical Industries Ltd · the 50 most recent filings